![](/img/cover-not-exists.png)
Synergistic cancer immunotherapy combines MVA-CD40L induced innate and adaptive immunity with tumor targeting antibodies
Medina-Echeverz, José, Hinterberger, Maria, Testori, Marco, Geiger, Marlene, Giessel, Raphael, Bathke, Barbara, Kassub, Ronny, Gräbnitz, Fabienne, Fiore, Giovanna, Wennier, Sonia T., Chaplin, Paul, SuVolume:
10
Language:
english
Journal:
Nature Communications
DOI:
10.1038/s41467-019-12998-6
Date:
December, 2019
File:
PDF, 1.26 MB
english, 2019